Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors.
about
The P2X7 receptor is a key modulator of aerobic glycolysisMolecular and functional properties of P2X receptors--recent progress and persisting challengesPurinergic signalling and cancerP2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathwaysProtein Profiling of Bladder Urothelial Cell CarcinomaBasal release of ATP: an autocrine-paracrine mechanism for cell regulation.P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.The hyposensitive N187D P2X7 mutant promotes malignant progression in nude mice.P2X7 mediates ATP-driven invasiveness in prostate cancer cells.Localization of P2X receptor subtypes 2, 3 and 7 in human urinary bladder.P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.P2X(7) receptor: Death or life?The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomasCell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor traffickingP2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin.Purinergic receptor-mediated effects of adenosine 5'-triphosphate in urological malignant diseases.P2X7 Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis.ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.Purinergic signalling in the lower urinary tract.Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.Targeting P2X₇ receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes.Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth.P2X(7): a growth-promoting receptor-implications for cancer.Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.Purinergic Signalling: Therapeutic Developments.A phase I clinical trial demonstrates that nfP2X7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway.Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators.Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptorsP2X7 receptors are a potential novel target for anti-glioma therapies
P2860
Q24296731-78B07D9C-4045-4086-B6A3-469CD7FC35B3Q24617046-E18A12B5-72E9-4D27-ABE7-4317CF7B1854Q24618782-8CFD15C2-4369-42A2-94C9-BEB54C5FFD97Q24655197-395FC342-9A47-4A52-BA83-4279BC5A5CFCQ27324419-A0F66A5A-4583-4F3A-90E1-318013AA7755Q34020834-5EECF13A-F255-4BBD-9A13-12B31192BC87Q34152239-E3AB6030-A115-4CD3-BD43-0BA69F3479DCQ34195588-FBAAFB44-428F-4CAB-BA70-40EF411593A1Q34285496-9A5D95CC-A21B-40F9-B094-1F473E55E60AQ35500124-E25D444B-A1A1-476F-8139-8A79B2C8021FQ35740154-B2CBDEEC-40F1-45F2-8660-29F497C5B5E2Q36092896-07800F68-EDCD-4347-B81B-B251BACB189FQ36173773-83F23011-6EBC-415E-91F0-59294E2E193DQ36813607-A45B11E0-048E-4377-944E-E46C01178E97Q37203208-B501DD30-9DF6-4B86-ADDE-3B233CD6C950Q37279471-C367FA4B-EBD4-46A9-A855-FD4B2D438E4BQ37381770-A7A40A8F-81D7-44D6-99DD-BBEE8A60E80BQ37631027-725F00C7-3A9B-4D6F-A6DE-66781AFB6EECQ37680218-154CBE38-63CA-41D4-89AF-4BD59194314CQ38005034-C51946D0-B656-4DF9-8C47-BACFDA666B84Q38061933-336E5CB1-99E3-4FD8-B655-7654174A2B8BQ38285850-478A62E2-8C0B-42F1-9069-58BA6029775DQ39665737-FED4E541-952B-4DCB-B28A-7008A8FB5B48Q39885707-EA5B5525-4B95-4BE2-A975-E062ABEA9C76Q40420727-4929ADFF-A492-4C89-B7B0-4F9986A1B214Q42087948-4483C240-D5B0-4A98-965E-91DB5C051FD7Q42316250-7DBBBE7B-3317-498A-9144-0EBBA3F010E7Q42367885-0C7E15E1-2277-405E-91C3-0F99F193C67AQ42505092-D0615AED-0079-4340-8206-B8BD1B373537Q47571865-83ADD3F3-9944-4F08-B95E-517C37D9B86CQ53244075-E0B99091-08C7-4E25-836D-A73E63386F37Q55030135-37387A44-ED13-4F63-9BB7-947D4A4B804EQ56828276-5751E805-992C-4688-97A6-46EB452650A0Q59321165-B868FDDC-8263-45C2-A790-68539A9D51BE
P2860
Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@en
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@nl
type
label
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@en
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@nl
prefLabel
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@en
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@nl
P2093
P2860
P1433
P1476
Early prostate cancer detected ...... onal cytolytic P2X7 receptors.
@en
P2093
Danieletto S
Gidley-Baird A
P2860
P304
P356
10.1111/J.0309-0167.2004.01798.X
P577
2004-03-01T00:00:00Z